This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirai, H
Right arrow Articles by Varmus, H E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirai, H
Right arrow Articles by Varmus, H E

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 April; 10(4): 1307-1318

Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.

H Hirai and H E Varmus

Department of Microbiology, University of California, San Francisco 94143-0502.

ABSTRACT

The products of the viral and cellular src genes, p60v-src and p60c-src, appear to be composed of multiple functional domains. Highly conserved regions called src homology 2 and 3 (SH2 and SH3), comprising amino acid residues 88 to 250, are believed to modulate the protein-tyrosine kinase activity present in the carboxy-terminal halves of the src proteins. To explore the functions of these regions more fully, we have made 34 site-directed mutations in a transformation-competent c-src gene encoding phenylalanine in place of tyrosine 527 (Y527F c-src). Twenty of the new mutations change only one or two amino acids, and the remainder delete small or large portions of the SH2-SH3 region. These mutant alleles have been incorporated into a replication-competent Rous sarcoma virus vector to examine the biochemical and biological properties of the mutant proteins after infection of chicken embryo fibroblasts. Four classes of mutant proteins were observed: class 1, mutants with only slight differences from the parental gene products; class 2, mutant proteins with diminished transforming and specific kinase activities; class 3, mutant proteins with normal or enhanced specific kinase activity but impaired biological activity, often as a consequence of instability; and class 4, mutant proteins with augmented biological and catalytic activities. In general, there was a strong correlation between total kinase activity (or amounts of intracellular phosphotyrosine-containing proteins) and transforming activity. Deletion mutations and some point mutations affecting residues 109 to 156 inhibited kinase and transforming functions, whereas deletions affecting residues 187 to 226 generally had positive effects on one or both of those functions, confirming that SH2-SH3 has complex regulatory properties. Five mutations that augmented the transforming and kinase activities of Y527F c-src [F172P, R175L, delta(198-205), delta(206-226), and delta(176-226)] conferred transformation competence on an otherwise normal c-src gene, indicating that mutations in SH2 (like previously described lesions in SH3, the kinase domain, and a carboxy-terminal inhibitory domain) can activate c-src.

Mol Cell Biol. 1990 April; 10(4): 1307-1318




This article has been cited by other articles:

  • Solheim, S. A., Torgersen, K. M., Tasken, K., Berge, T. (2008). Regulation of FynT Function by Dual Domain Docking on PAG/Cbp. J. Biol. Chem. 283: 2773-2783 [Abstract] [Full Text]  
  • Kalakonda, S., Nallar, S. C., Gong, P., Lindner, D. J., Goldblum, S. E., Reddy, S. P., Kalvakolanu, D. V. (2007). Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels. Am. J. Pathol. 171: 1352-1368 [Abstract] [Full Text]  
  • Yeo, M. G., Partridge, M. A., Ezratty, E. J., Shen, Q., Gundersen, G. G., Marcantonio, E. E. (2006). Src SH2 Arginine 175 Is Required for Cell Motility: Specific Focal Adhesion Kinase Targeting and Focal Adhesion Assembly Function. Mol. Cell. Biol. 26: 4399-4409 [Abstract] [Full Text]  
  • Harris, K. F., Shoji, I., Cooper, E. M., Kumar, S., Oda, H., Howley, P. M. (1999). Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl. Acad. Sci. USA 96: 13738-13743 [Abstract] [Full Text]  
  • LaFevre-Bernt, M., Sicheri, F., Pico, A., Porter, M., Kuriyan, J., Miller, W. T. (1998). Intramolecular Regulatory Interactions in the Src Family Kinase Hck Probed by Mutagenesis of a Conserved Tryptophan Residue. J. Biol. Chem. 273: 32129-32134 [Abstract] [Full Text]  
  • Ziemnicka-Kotula, D., Xu, J., Gu, H., Potempska, A., Kim, K. S., Jenkins, E. C., Trenkner, E., Kotula, L. (1998). Identification of a Candidate Human Spectrin Src Homology 3 Domain-binding Protein Suggests a General Mechanism of Association of Tyrosine Kinases with the Spectrin-based Membrane Skeleton. J. Biol. Chem. 273: 13681-13692 [Abstract] [Full Text]  
  • Wen, S.-T., Van Etten, R. A. (1997). The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11: 2456-2467 [Abstract] [Full Text]  
  • Kanemitsu, M. Y., Loo, L. W. M., Simon, S., Lau, A. F., Eckhart, W. (1997). Tyrosine Phosphorylation of Connexin 43 by v-Src Is Mediated by SH2 and SH3 Domain Interactions. J. Biol. Chem. 272: 22824-22831 [Abstract] [Full Text]  
  • Briggs, S. D., Sharkey, M., Stevenson, M., Smithgall, T. E. (1997). SH3-mediated Hck Tyrosine Kinase Activation and Fibroblast Transformation by the Nef Protein of HIV-1. J. Biol. Chem. 272: 17899-17902 [Abstract] [Full Text]  
  • Weijland, A., Williams, J. C., Neubauer, G., Courtneidge, S. A., Wierenga, R. K., Superti-Furga, G. (1997). Src regulated by C-terminal phosphorylation is monomeric. Proc. Natl. Acad. Sci. USA 94: 3590-3595 [Abstract] [Full Text]  
  • Broome, M. A., Hunter, T. (1996). Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic Signaling. J. Biol. Chem. 271: 16798-16806 [Abstract] [Full Text]  
  • Nakamoto, T., Sakai, R., Ozawa, K., Yazaki, Y., Hirai, H. (1996). Direct Binding of C-terminal Region of p130[IMAGE] to SH2 and SH3 Domains of Src Kinase. J. Biol. Chem. 271: 8959-8965 [Abstract] [Full Text]  
  • Kawakatsu, H., Sakai, T., Takagaki, Y., Shinoda, Y., Saito, M., Owada, M. K., Yano, J. (1996). A New Monoclonal Antibody Which Selectively Recognizes the Active Form of Src Tyrosine Kinase. J. Biol. Chem. 271: 5680-5685 [Abstract] [Full Text]  
  • Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., Lehman, D. (1995). Characterization of the Mammalian YAP (Yes-associated Protein) Gene and Its Role in Defining a Novel Protein Module, the WW Domain. J. Biol. Chem. 270: 14733-14741 [Abstract] [Full Text]  
  • Abrams, C. S., Zhao, W. (1995). SH3 Domains Specifically Regulate Kinase Activity of Expressed Src Family Proteins. J. Biol. Chem. 270: 333-339 [Abstract] [Full Text]  
  • Ren, R, Mayer, B., Cicchetti, P, Baltimore, D (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161 [Abstract]  
  • Boschelli, F, Uptain, S., Lightbody, J. (1993). The lethality of p60v-src in Saccharomyces cerevisiae and the activation of p34CDC28 kinase are dependent on the integrity of the SH2 domain. J. Cell Sci. 105: 519-528 [Abstract]  
  • Cicchetti, P, Mayer, B., Thiel, G, Baltimore, D (1992). Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257: 803-806 [Abstract]  
  • Bellacosa, A, Testa, JR, Staal, S., Tsichlis, P. (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277 [Abstract]  
  • Koch, C., Anderson, D, Moran, M., Ellis, C, Pawson, T (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674 [Abstract]  
  • Hirai, H, Varmus, H E (1990). SH2 mutants of c-src that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated c-src.. Genes Dev. 4: 2342-2352 [Abstract]  
  • Brasher, B. B., Van Etten, R. A. (2000). c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines. J. Biol. Chem. 275: 35631-35637 [Abstract] [Full Text]  
  • Profit, A. A., Lee, T. R., Niu, J., Lawrence, D. S. (2001). Molecular Rulers: An Assessment of Distance and Spatial Relationships of Src Tyrosine Kinase SH2 and Active Site Regions. J. Biol. Chem. 276: 9446-9451 [Abstract] [Full Text]  
  • Barnes, H., Larsen, B., Tyers, M., van der Geer, P. (2001). Tyrosine-phosphorylated Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Associates with the Adaptor Protein SHC in SRC-transformed Cells. J. Biol. Chem. 276: 19119-19125 [Abstract] [Full Text]  
  • Smith, K. M., Van Etten, R. A. (2001). Activation of c-Abl Kinase Activity and Transformation by a Chemical Inducer of Dimerization. J. Biol. Chem. 276: 24372-24379 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»